Malignant tenosynovial giant cell tumor (TGCT) is a rare clinical entity that can arise as a recurrent lesion or can co‑exist with a benign TGCT lesion. Malignant TGCT most commonly arises in the lower extremity and tends to be clinically aggressive, with most patients developing recurrent lesions or dying. Much of the literature describes the histopathologic features and classifies this broad group of tumors, with little description of the imaging characteristics of this disease. We present the multimodality appearance of a case of malignant diffuse‑type TGCT that recurred 2 months after resection with subsequent rapid clinical progression.
Casper Falster, Simon Stockmann Poulsen and Uffe Joergensen (2017) A rare case of localised pigmented villonodular synovitis in the knee of a 24-year-old female soccer player: diagnosis, management and summary of tenosynovial giant cell tumours. BMJ Case Reports:bcr-2017-219549. doi: 10.1136/bcr-2017-219549
Alyaa Al-Ibraheemi, William Albert Ahrens, Karen Fritchie, Jie Dong, Andre M. Oliveira, Bonnie Balzer and Andrew L. Folpe (2019) Malignant Tenosynovial Giant Cell Tumor: The True “Synovial Sarcoma?” A Clinicopathologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases, Supporting Origin from Synoviocytes. Mod Pathol32(2):242. doi: 10.1038/s41379-018-0129-0
Robert Nakayama, Jyothi Priya Jagannathan, Nikhil Ramaiya, Marco L. Ferrone, Chandrajit P. Raut, John E. Ready, Jason L. Hornick and Andrew J. Wagner (2018) Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy. BMC Cancer18(1):. doi: 10.1186/s12885-018-5188-6
Soo Jung Kim, Yong-Koo Kang, Chang Young Yoo and Jee Young Kim (2016) Tenosynovial Giant Cell Tumor of the Pes Anserine Bursa with Bone Marrow Extension into the Tibia: A Case Report. J Korean Soc Radiol75(4):322. doi: 10.3348/jksr.2016.75.4.322
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.